Literature DB >> 1919566

Lack of correspondence between mRNA expression for a putative cell death molecule (SGP-2) and neuronal cell death in the central nervous system.

G A Garden1, M Bothwell, E W Rubel.   

Abstract

Neuronal death during nervous system development, a widely observed phenomenon, occurs through unknown mechanisms. Recent evidence suggests an active, destructive process requiring new gene expression. Sulfated glycoprotein-2 (SGP-2), a secretory product of testicular Sertoli cells has been shown to up-regulate in several nonneural tissues undergoing programmed cell death and in several types of neuronal degeneration. In order to determine if this message up-regulates in neurons undergoing developmentally determined cell death, we have studied the expression of SGP-2 mRNA in the developing and adult rat central nervous system (CNS) with in situ hybridization. We also report on the expression of this message in nonneural tissues from several regions of the developing embryo. The developing and adult rat central nervous system as well as widely varied tissues in the rat embryo express SGP-2 mRNA in a pattern that does not correlate with regions undergoing developmental cell death. In the nervous system, SGP-2 mRNA is expressed in neuronal populations including motor neurons, cortical neurons, and hypothalamic neurons at ages when the period of developmental cell death has passed. In a nonneural tissue (palatal shelve epithelium) for which a developmental cell death period has been described, SGP-2 mRNA was not present in the region where cell death occurs. We conclude that SGP-2 mRNA expression cannot be correlated with programmed cell death in neural or nonneural tissues. The results of this study as well as recently reported SGP-2 homologies indicate a possible role for this protein in secretion and lipid transport.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1919566     DOI: 10.1002/neu.480220605

Source DB:  PubMed          Journal:  J Neurobiol        ISSN: 0022-3034


  8 in total

1.  Apolipoproteins in the brain: implications for neurological and psychiatric disorders.

Authors:  David A Elliott; Cyndi Shannon Weickert; Brett Garner
Journal:  Clin Lipidol       Date:  2010-08-01

2.  Clusterin in human gut-associated lymphoid tissue, tonsils, and adenoids: localization to M cells and follicular dendritic cells.

Authors:  Phebe Verbrugghe; Pekka Kujala; Wim Waelput; Peter J Peters; Claude A Cuvelier
Journal:  Histochem Cell Biol       Date:  2007-12-21       Impact factor: 4.304

3.  Apolipoprotein J expression at fluid-tissue interfaces: potential role in barrier cytoprotection.

Authors:  B J Aronow; S D Lund; T L Brown; J A Harmony; D P Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

4.  Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death.

Authors:  L E French; A Wohlwend; A P Sappino; J Tschopp; J A Schifferli
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

5.  Clusterin/Apolipoprotein J immunolocalization on carotid artery is affected by TNF-alpha, cigarette smoking and anti-platelet treatment.

Authors:  Amalia E Yanni; George Agrogiannis; Christos Gkekas; Despina Perrea
Journal:  Lipids Health Dis       Date:  2014-04-23       Impact factor: 3.876

6.  Development of a Label-Free Immunosensor for Clusterin Detection as an Alzheimer's Biomarker.

Authors:  Kamrul Islam; Samar Damiati; Jagriti Sethi; Ahmed Suhail; Genhua Pan
Journal:  Sensors (Basel)       Date:  2018-01-20       Impact factor: 3.576

7.  Brain clusterin protein isoforms and mitochondrial localization.

Authors:  Sarah K Herring; Hee-Jung Moon; Punam Rawal; Anindit Chhibber; Liqin Zhao
Journal:  Elife       Date:  2019-11-18       Impact factor: 8.140

8.  Murine clusterin: molecular cloning and mRNA localization of a gene associated with epithelial differentiation processes during embryogenesis.

Authors:  L E French; A Chonn; D Ducrest; B Baumann; D Belin; A Wohlwend; J Z Kiss; A P Sappino; J Tschopp; J A Schifferli
Journal:  J Cell Biol       Date:  1993-09       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.